CONTACT INFORMATION http://www.loyola.org
Patrick Stiff
M.D.
  • Coleman Professor of Oncology
  • Director, Cancer Center
  • FCO Division Director, Hematology/Oncology
  • Medical Director, Cancer Center
  • Hematology/Oncology
  • Pathology
Specialties
Leukemia, Ovarian Cancer, Non-Hodgkin's Lymphoma, Bone Marrow Transplantation
Board Certifications
  • Hematology - Subspecialty Cert: AM Board of Internal Medicine
  • Internal Medicine - General Cert: AM Board of Internal Medicine
  • Medical Oncology - Subspecialty Cert: AM Board of Internal Medicine
Publications

Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftmentHorwitz,M. E.; Chao,N. J.; Rizzieri,D. A.; Long,G. D.; Sullivan,K. M.; Gasparetto,C.; Chute,J. P.; Morris,A.; McDonald,C.; Waters-Pick,B.; Stiff,P.; Wease,S.; Peled,A.; Snyder,D.; Cohen,E. G.; Shoham,H.; Landau,E.; Friend,E.; Peleg,I.; Aschengrau,D.; Yackoubov,D.; Kurtzberg,J.; Peled,T.The Journal of clinical investigation 2014 ; ( ):

Neurologic aspects of plasma cell disordersSobol,U.; Stiff,P.Handbook of clinical neurology 2014 ;120( ):1083-1099

Donor cell myeloid sarcomaWalshauser,M. A.; Go,A.; Sojitra,P.; Venkataraman,G.; Stiff,P.Case reports in hematology 2014 ;2014( ):153989

Seven-year follow-up of allogeneic transplant using BCNU, etoposide, cytarabine and melphalan chemotherapy in patients with Hodgkin lymphoma after autograft failure: importance of minimal residual diseaseSobol,U.; Rodriguez,T.; Smith,S.; Go,A.; Vimr,R.; Parthasarathy,M.; Guo,R.; Stiff,P.Leukemia & lymphoma 2014 ;55(6):1281-1287

Clinical Significance of MYC Expression and/or "High-grade" Morphology in Non-Burkitt, Diffuse Aggressive B-cell Lymphomas: A SWOG S9704 Correlative StudyCook,J. R.; Goldman,B.; Tubbs,R. R.; Rimsza,L.; Leblanc,M.; Stiff,P.; Fisher,R.The American Journal of Surgical Pathology 2014 ;38(4):494-501

A potential role for B cells in suppressed immune responses in cord blood transplant recipientsBeaudette-Zlatanova,B. C.; Le,P. T.; Knight,K. L.; Zhang,S.; Zakrzewski,S.; Parthasarathy,M.; Stiff,P. J.Bone marrow transplantation 2013 ;48(1):85-93

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphomaStiff,P. J.; Unger,J. M.; Cook,J. R.; Constine,L. S.; Couban,S.; Stewart,D. A.; Shea,T. C.; Porcu,P.; Winter,J. N.; Kahl,B. S.; Miller,T. P.; Tubbs,R. R.; Marcellus,D.; Friedberg,J. W.; Barton,K. P.; Mills,G. M.; LeBlanc,M.; Rimsza,L. M.; Forman,S. J.; Fisher,R. I.The New England journal of medicine 2013 ;369(18):1681-1690

Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496)Gordon,L. I.; Hong,F.; Fisher,R. I.; Bartlett,N. L.; Connors,J. M.; Gascoyne,R. D.; Wagner,H.; Stiff,P. J.; Cheson,B. D.; Gospodarowicz,M.; Advani,R.; Kahl,B. S.; Friedberg,J. W.; Blum,K. A.; Habermann,T. M.; Tuscano,J. M.; Hoppe,R. T.; Horning,S. J.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 ;31(6):684-691

Dendritic cell immunotherapy in ovarian cancerStiff,P. J.; Czerlanis,C.; Drakes,M. L.Expert Review of Anticancer Therapy 2013 ;13(1):43-53

Salvage Second Hematopoietic Cell Transplantation in MyelomaMichaelis,L. C.; Saad,A.; Zhong,X.; Le-Rademacher,J.; Freytes,C. O.; Marks,D. I.; Lazarus,H. M.; Bird,J. M.; Holmberg,L.; Kamble,R. T.; Kumar,S.; Lill,M.; Meehan,K. R.; Saber,W.; Schriber,J.; Tay,J.; Vogl,D. T.; Wirk,B.; Savani,B. N.; Gale,R. P.; Vesole,D. H.; Schiller,G. J.; Abidi,M.; Anderson,K. C.; Nishihori,T.; Kalaycio,M. E.; Vose,J. M.; Moreb,J. S.; Drobyski,W.; Munker,R.; Roy,V.; Ghobadi,A.; Holland,H. K.; Nath,R.; To,L. B.; Maiolino,A.; Kassim,A. A.; Giralt,S. A.; Landau,H.; Schouten,H. C.; Maziarz,R. T.; Michael,J.; Kindwall-Keller,T.; Stiff,P. J.; Gibson,J.; Lonial,S.; Krishnan,A.; Dispenzieri,A.; Hari,P.; Plasma Cell Disorders Working Committee of the Center for International Blood and Marrow Transplant ResearchBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013 ;19(5):760-766

Prevention of nausea and vomiting associated with stem cell transplant: results of a prospective, randomized trial of aprepitant used with highly emetogenic preparative regimensStiff,P. J.; Fox-Geiman,M. P.; Kiley,K.; Rychlik,K.; Parthasarathy,M.; Fletcher-Gonzalez,D.; Porter,N.; Go,A.; Smith,S. E.; Rodriguez,T. E.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013 ;19(1):49-55.e1

Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants.Mumby,P. B.; Hurley,C.; Samsi,M.; Thilges,S.; Parthasarathy,M.; Stiff,P. J.Bone marrow transplantation 2012 ;47(4):556-561

Comparison of early quality of life outcomes in autologous and allogeneic transplant patientsGarcia,C. M.; Mumby,P. B.; Thilges,S.; Stiff,P. J.Bone marrow transplantation 2012 ;47(12):1577-1582

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research studyArmand,P.; Kim,H. T.; Zhang,M. J.; Perez,W. S.; Dal Cin,P. S.; Klumpp,T. R.; Waller,E. K.; Litzow,M. R.; Liesveld,J. L.; Lazarus,H. M.; Artz,A. S.; Gupta,V.; Savani,B. N.; McCarthy,P. L.; Cahn,J. Y.; Schouten,H. C.; Finke,J.; Ball,E. D.; Aljurf,M. D.; Cutler,C. S.; Rowe,J. M.; Antin,J. H.; Isola,L. M.; Di Bartolomeo,P.; Camitta,B. M.; Miller,A. M.; Cairo,M. S.; Stockerl-Goldstein,K.; Sierra,J.; Savoie,M. L.; Halter,J.; Stiff,P. J.; Nabhan,C.; Jakubowski,A. A.; Bunjes,D. W.; Petersdorf,E. W.; Devine,S. M.; Maziarz,R. T.; Bornhauser,M.; Lewis,V. A.; Marks,D. I.; Bredeson,C. N.; Soiffer,R. J.; Weisdorf,D. J.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012 ;18(2):280-288

TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomesChoi,S. W.; Stiff,P.; Cooke,K.; Ferrara,J. L.; Braun,T.; Kitko,C.; Reddy,P.; Yanik,G.; Mineishi,S.; Paczesny,S.; Hanauer,D.; Pawarode,A.; Peres,E.; Rodriguez,T.; Smith,S.; Levine,J. E.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012 ;18(10):1525-1532

A human thymic epithelial cell culture system for the promotion of lymphopoiesis from hematopoietic stem cells.Beaudette-Zlatanova,B. C.; Knight,K. L.; Zhang,S.; Stiff,P. J.; Zuniga-Pflucker,J. C.; Le,P. T.Experimental hematology 2011 ;39(5):570-579

Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myelomaStiff,P. J.; Micallef,I.; Nademanee,A. P.; Stadtmauer,E. A.; Maziarz,R. T.; Bolwell,B. J.; Bridger,G.; Marulkar,S.; Hsu,F. J.; DiPersio,J. F.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011 ;17(8):1146-1153

High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma.Stiff,P. J.; Agovi,M. A.; Antman,K. H.; Blaise,D.; Camitta,B. M.; Cairo,M. S.; Childs,R. W.; Edwards,J. R.; Gale,R. P.; Hale,G. A.; Lazarus,H. M.; Arora,M.Biology of Blood & Marrow Transplantation 2010 ;16(4):525-532

The impact of pharmacotherapy on depression and quality of life in patients undergoing a bone marrow transplant (BMT).Mumby,P. B.; Garcia,C.; Trivedi-Purohit,R.; Gourvitz,R.; Rychlik,K.; Rodriguez,T.; Smith,S. E.; Toor,A. A.; Rao,M.; Stiff,P. J.ASCO Meeting Abstracts 2010 ;28(15_suppl):9132

Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation.Gerds,A.; Fox-Geiman,M.; Dawravoo,K.; Rodriguez,T.; Toor,A.; Smith,S.; Kiley,K.; Fletcher-Gonzalez,D.; Hicks,C.; Stiff,P.Biology of Blood & Marrow Transplantation 2010 ;16(5):678-685

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumSmith,S. M.; van Besien,K.; Karrison,T.; Dancey,J.; McLaughlin,P.; Younes,A.; Smith,S.; Stiff,P.; Lester,E.; Modi,S.; Doyle,L. A.; Vokes,E. E.; Pro,B.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(31):4740-4746

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern eraEvens,A. M.; David,K. A.; Helenowski,I.; Nelson,B.; Kaufman,D.; Kircher,S. M.; Gimelfarb,A.; Hattersley,E.; Mauro,L. A.; Jovanovic,B.; Chadburn,A.; Stiff,P.; Winter,J. N.; Mehta,J.; Van Besien,K.; Gregory,S.; Gordon,L. I.; Shammo,J. M.; Smith,S. E.; Smith,S. M.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 ;28(6):1038-1046

Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemiaAdvani,A. S.; Gundacker,H. M.; Sala-Torra,O.; Radich,J. P.; Lai,R.; Slovak,M. L.; Lancet,J. E.; Coutre,S. E.; Stuart,R. K.; Mims,M. P.; Stiff,P. J.; Appelbaum,F. R.British journal of haematology 2010 ;151(5):430-434

c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.Guo,Y.; Niu,C.; Breslin,P.; Tang,M.; Zhang,S.; Wei,W.; Kini,A. R.; Paner,G. P.; Alkan,S.; Morris,S. W.; Diaz,M.; Stiff,P. J.; Zhang,J.Blood 2009 ;114(10):2097-2106

Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphomaDiPersio,J. F.; Micallef,I. N.; Stiff,P. J.; Bolwell,B. J.; Maziarz,R. T.; Jacobsen,E.; Nademanee,A.; McCarty,J.; Bridger,G.; Calandra,G.; 3101 InvestigatorsJournal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 ;27(28):4767-4773

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myelomaDiPersio,J. F.; Stadtmauer,E. A.; Nademanee,A.; Micallef,I. N.; Stiff,P. J.; Kaufman,J. L.; Maziarz,R. T.; Hosing,C.; Fruehauf,S.; Horwitz,M.; Cooper,D.; Bridger,G.; Calandra,G.; 3102 InvestigatorsBlood 2009 ;113(23):5720-5726

Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.Stiff,P. J.; Bensinger,W.; Abidi,M. H.; Gingrich,R.; Artz,A. S.; Nademanee,A.; Hansen,K. S.; Sobczak,C.; Cutler,C.; Bolwell,B.; Shore,T. B.; Lazarus,H. M.; Yeager,A. M.; Lovelace,W.; Guo,M.; Dreiling,L.Biology of Blood & Marrow Transplantation 2009 ;15(7):827-834

Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient.Stiff,P.; Micallef,I.; McCarthy,P.; Magalhaes-Silverman,M.; Weisdorf,D.; Territo,M.; Badel,K.; Calandra,G.Biology of Blood & Marrow Transplantation 2009 ;15(2):249-256

Managing hematopoietic stem-cell transplant resources: the case for outpatient transplantationStiff,P. J.Leukemia & lymphoma 2009 ;50(1):6-7

Successful stem cell remobilization using plerixafor (mozobil) plus granulocyte colony-stimulating factor in patients with non-hodgkin lymphoma: results from the plerixafor NHL phase 3 study rescue protocolMicallef,I. N.; Stiff,P. J.; DiPersio,J. F.; Maziarz,R. T.; McCarty,J. M.; Bridger,G.; Calandra,G.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009 ;15(12):1578-1586

Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancerChew,H. K.; Doroshow,J. H.; Frankel,P.; Margolin,K. A.; Somlo,G.; Lenz,H. J.; Gordon,M.; Zhang,W.; Yang,D.; Russell,C.; Spicer,D.; Synold,T.; Bayer,R.; Hantel,A.; Stiff,P. J.; Tetef,M. L.; Gandara,D. R.; Albain,K. S.Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 ;27(13):2163-2169

Inverse relationship between dendritic cell CCR9 expression and maturation state.Drakes,M. L.; Stiff,P. J.; Blanchard,T. G.Immunology 2009 ;127(4):466-476

Allogeneic hematopoietic cell transplantation for metastatic breast cancerUeno,N. T.; Rizzo,J. D.; Demirer,T.; Cheng,Y. C.; Hegenbart,U.; Zhang,M. J.; Bregni,M.; Carella,A.; Blaise,D.; Bashey,A.; Bitran,J. D.; Bolwell,B. J.; Elfenbein,G. J.; Fields,K. K.; Freytes,C. O.; Gale,R. P.; Lazarus,H. M.; Champlin,R. E.; Stiff,P. J.; Niederwieser,D.Bone marrow transplantation 2008 ;41(6):537-545

Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trialNand,S.; Godwin,J.; Smith,S.; Barton,K.; Michaelis,L.; Alkan,S.; Veerappan,R.; Rychlik,K.; Germano,E.; Stiff,P.Leukemia & lymphoma 2008 ;49(11):2141-2147

Feasibility of conditioning with thymoglobulin and reduced intensity TBI to reduce acute GVHD in recipients of allogeneic SCTToor,A.; Rodriguez,T.; Bauml,M.; Mathews,H.; Shanti,S.; Senitzer,D.; Kini,A.; Norton,J.; Parthasarathy,M.; Mohideen,N.; Petrowsky,C.; Bonilla,B.; Smith,S.; Stiff,P.Bone marrow transplantation 2008 ;42(11):723-731

Clinical utility of autopsy after hematopoietic stem cell transplantationHofmeister,C. C.; Marinier,D. E.; Czerlanis,C.; Stiff,P. J.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007 ;13(1):26-30

Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic nicheHofmeister,C. C.; Zhang,J.; Knight,K. L.; Le,P.; Stiff,P. J.Bone marrow transplantation 2007 ;39(1):11-23

Utility of single versus tandem autotransplants for advanced testes/germ cell cancer: a center for international blood and marrow transplant research (CIBMTR) analysisLazarus,H. M.; Stiff,P. J.; Carreras,J.; Logan,B. R.; Akard,L.; Bolwell,B. J.; Childs,R. W.; Gale,R. P.; Klein,J. P.; Lill,M. C.; Perez,W. S.; Stadtmauer,E. A.; Rizzo,J. D.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007 ;13(7):778-789

Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial resultsElting,L. S.; Shih,Y. C.; Stiff,P. J.; Bensinger,W.; Cantor,S. B.; Cooksley,C.; Spielberger,R.; Emmanoulides,C.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007 ;13(7):806-813

Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.Mullane,K.; Toor,A. A.; Kalnicky,C.; Rodriguez,T.; Klein,J.; Stiff,P.Transplant Infectious Disease 2007 ;9(2):89-96

Mucositis: continuing progress for a continuing needStiff,P. J.The Journal of Supportive Oncology 2007 ;5(4 Suppl 2):47-62

Alefacept in corticosteroid refractory graft versus host disease: early results indicate promising activityToor,A. A.; Stiff,P. J.; Nickoloff,B. J.; Rodriguez,T.; Klein,J. L.; Gordon,K. B.The Journal of dermatological treatment 2007 ;18(1):13-18

The administration of polymerized human hemoglobin (Pyridoxylated) to a Jehovah's Witness after submyeloablative stem cell transplantation complicated by delayed graft failureSmith,S. E.; Toor,A.; Rodriguez,T.; Stiff,P.Comprehensive therapy 2006 ;32(3):172-175

Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basisStiff,P.; Mumby,P.; Miler,L.; Rodriguez,T.; Parthswarthy,M.; Kiley,K.; Porter,N.; Batiste,R.; Wojtowitz,S.; Lichtenstein,S.; Fox-Geiman,M.; Toor,A.Bone marrow transplantation 2006 ;38(11):757-764

Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation settingStiff,P. J.; Emmanouilides,C.; Bensinger,W. I.; Gentile,T.; Blazar,B.; Shea,T. C.; Lu,J.; Isitt,J.; Cesano,A.; Spielberger,R.Journal of Clinical Oncology 2006 ;24(33):5186-5193

Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT).Stiff,P. J.; Erder,H.; Bensinger,W. I.; Emmanouilides,C.; Gentile,T.; Isitt,J.; Lu,Z. J.; Spielberger,R.Bone marrow transplantation 2006 ;37(4):393-401

Patients' understanding of disease status and treatment plan at initial hematopoietic stem cell transplantation consultation.Stiff,P. J.; Miller,L. A.; Mumby,P.; Kiley,K.; Batiste,R.; Porter,N.; Potocki,K.; Volle,M.; Lichtenstein,S.; Wojtowicz,S.; Zakrzewski,S.; Toor,A.; Rodriguez,T.Bone marrow transplantation 2006 ;37(5):479-484

Retrospective utility of bronchoscopy after hematopoietic stem cell transplant.Hofmeister,C. C.; Czerlanis,C.; Forsythe,S.; Stiff,P. J.Bone marrow transplantation 2006 ;38(10):693-698

Mucosal protection by cytokines.Hofmeister,C. C.; Stiff,P. J.Current Hematology Reports 2005 ;4(6):446-453

Recurrent steroid-responsive pancreatitis associated with myelodysplastic syndrome and transformations.Tanvetyanon,T.; Stiff,P. J.Leukemia & lymphoma 2005 ;46(1):151-154

Oral mucositis therapy comes of ageStiff,P. J.Journal of Supportive Oncology 2005 ;3(2):73-75

Second allografts for relapsed hematologic malignancies: feasibility of using a different donor.Duus,J. E.; Stiff,P. J.; Choi,J.; Parthasarathy,M.; Rodriguez,T.; Toor,A. A.Bone marrow transplantation 2005 ;35(3):261-264

Analysis of remobilization success in patients undergoing autologous stem cell transplants who fail an initial mobilization: risk factors, cytokine use and cost.Boeve,S.; Strupeck,J.; Creech,S.; Stiff,P. J.Bone marrow transplantation 2004 ;33(10):997-1003

The challenges of oral mucositis and its therapyStiff,P. J.The Journal of Supportive Oncology 2004 ;2(2 Suppl 2):70-72

Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study.Stiff,P. J.; Shpall,E. J.; Liu,P. Y.; Wilczynski,S. P.; Callander,N. S.; Scudder,S. A.; Jazieh,A. R.; Samlowski,W.; McCoy,J.; Alberts,D. S.Gynecologic oncology 2004 ;94(1):98-106

Favourable results with a single autologous stem cell transplant following conditioning with busulphan and cyclophosphamide in patients with multiple myelomaToor,A. A.; Ayers,J.; Strupeck,J.; Parthasarathy,M.; Creech,S.; Rodriguez,T.; Stiff,P. J.British journal of haematology 2004 ;124(6):769-776

Second allogeneic transplantation using a reduced-intensity preparative regimen for relapsed myelofibrosisTanvetyanon,T.; Stiff,P. J.American Journal of Hematology 2004 ;77(2):204-205

Post-transplant air-leak syndrome.Tanvetyanon,T.; Toor,A. A.; Stiff,P. J.British journal of haematology 2004 ;126(6):758

Graft-versus-host disease of the skin: life and death on the epidermal edgeHofmeister,C. C.; Quinn,A.; Cooke,K. R.; Stiff,P.; Nickoloff,B.; Ferrara,J. L.Biology of Blood & Marrow Transplantation 2004 ;10(6):366-372

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial.Stiff,P. J.; Unger,J. M.; Forman,S. J.; McCall,A. R.; LeBlanc,M.; Nademanee,A. P.; Bolwell,B. J.; Fisher,R. I.Biology of Blood & Marrow Transplantation 2003 ;9(8):529-539

Current treatment results of allogeneic bone marrow transplantation for acute myeloid and lymphoid leukemiaRodriguez,T. E.; Stiff,P. J.Current Hematology Reports 2003 ;2(4):295-301

BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective.Cooney,J. P.; Stiff,P. J.; Toor,A. A.; Parthasarathy,M.Biology of Blood & Marrow Transplantation 2003 ;9(3):177-182

Autologous stem cell transplantation for small cell lung cancerRizzo,J. D.; Elias,A. D.; Stiff,P. J.; Lazarus,H. M.; Zhang,M. J.; Oblon,D. J.; Pecora,A. L.; Hale,G. A.; Horowitz,M. M.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002 ;8(5):273-280

Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuliChen,B.; Stiff,P.; Sloan,G.; Kash,J.; Manjunath,R.; Pathasarathy,M.; Oldenburg,D.; Foreman,K. E.; Nickoloff,B. J.Clinical immunology (Orlando, Fla.) 2001 ;98(2):280-292

Status of high-dose chemotherapy for breast cancer: a reviewNieto,Y.; Champlin,R. E.; Wingard,J. R.; Vredenburgh,J. F.; Elias,A. D.; Richardson,P.; Glaspy,J.; Jones,R. B.; Stiff,P. J.; Bearman,S. I.; Cagnoni,P. J.; McSweeney,P. A.; LeMaistre,C. F.; Pecora,A. L.; Shpall,E. F.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000 ;6(5):476-495

Radiologic case study. Bone marrow transplant and multiple sites of osteonecrosisSimon,J.; Lomasney,L. M.; Demos,T. C.; Stiff,P. J.Orthopedics 2000 ;23(1):80, 73-5

High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry reportStiff,P. J.; Veum-Stone,J.; Lazarus,H. M.; Ayash,L.; Edwards,J. R.; Keating,A.; Klein,J. P.; Oblon,D. J.; Shea,T. C.; Thome,S.; Horowitz,M. M.Annals of Internal Medicine 2000 ;133(7):504-515

Education
Medical School
  • Loyola University Chicago Stritch School of Medicine
Residency
  • Cleveland Clinic Foundation, Internal Medicine: General
Fellowship
  • Memorial Sloan-Kettering Cancer Center, Internal Medicine: Hematology & Medical Oncology
Interests
  • Classical Music
  • Foreign Travel